Katie Cunningham, Growth Marketing Manager, Author at EverGlade

Katie Cunningham, Growth Marketing Manager

Katie Cunningham, Growth Marketing Manager

BARDA’s Next Big Investment Play: Pandemic Preparedness And Domestic Manufacturing

The Biomedical Advanced Research and Development Authority (BARDA) has been telegraphing its priorities for years, but the latest cluster of moves makes the picture sharper: the U.S. is shifting from “buy vaccines when a crisis hits” to owning the infrastructure that keeps pandemic response on a hair trigger. Three signals stand out: A new pre‑solicitation […]

BARDA’s Next Big Investment Play: Pandemic Preparedness And Domestic Manufacturing Read More »

MTEC’s FY26 Multi‑Topic RPP: Where Military Medicine, Prevention, And Infectious Disease Innovation Converge

The Medical Technology Enterprise Consortium (MTEC) has released its Fiscal Year 2026 Multi‑Topic Request for Project Proposals (MTEC‑26‑04‑MultiTopic), opening a wide lane for medical prototype and knowledge solutions that directly support force health and readiness. Enhanced White Papers are due October 30, 2026 at noon Eastern, and awards will be made under MTEC’s prototype OTA

MTEC’s FY26 Multi‑Topic RPP: Where Military Medicine, Prevention, And Infectious Disease Innovation Converge Read More »

DARPA Releases Official Solicitation for Protein ENGineering (PENG)

The Defense Advanced Research Projects Agency (DARPA), under the Defense Sciences Office (DSO), has released the full Program Solicitation for Protein ENGineering (PENG), DARPA-PS-26-129. The solicitation moves PENG from concept and Proposers Day into an active, multi‑phase program seeking innovative proposals to build a multifunctional, target‑agnostic platform for precise, programmable editing of endogenous proteins. PENG’s

DARPA Releases Official Solicitation for Protein ENGineering (PENG) Read More »

DARPA Launches PINPOINT Program To Break The GPS Dependency

The Defense Advanced Research Projects Agency (DARPA), under the Defense Sciences Office (DSO), has released a Broad Agency Announcement (BAA) for the Precision Inertial Navigation & Positioning On an Integrated Tesseract (PINPOINT) program, HR001126S0016. PINPOINT aims to deliver a new class of micro‑scale inertial measurement units (IMUs) that can provide GPS‑quality positioning and navigation over

DARPA Launches PINPOINT Program To Break The GPS Dependency Read More »

BARDA’s BioMaP Releases RPP on Domestic Manufacturing for Nitrile Gloves

ASPR And BARDA Move To Close The Nitrile Glove Gap The Biomedical Advanced Research and Development Authority (BARDA), through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP‑Consortium), has released a new Request for Project Proposals (RPP 26‑09‑Gloves) focused on Expansion of Domestic Manufacturing Capacity for Nitrile Gloves. ASPR’s Center for Industrial Base Management and Supply Chain (IBMSC)

BARDA’s BioMaP Releases RPP on Domestic Manufacturing for Nitrile Gloves Read More »

Sustaining Nitrile Glove Capacity With BARDA’s PPE Manufacturing Push

The Biomedical Advanced Research and Development Authority (BARDA), working through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP‑Consortium), has released a new Request for Project Proposals (RPP 26‑04‑NBR) focused on Sustainment of PPE Capacities – Nitrile Butadiene Rubber (NBR). ASPR’s Industrial Base Management and Supply Chain (IBMSC) is seeking projects that will sustain and strengthen domestic NBR

Sustaining Nitrile Glove Capacity With BARDA’s PPE Manufacturing Push Read More »

ARPA‑H’s ASCENT‑IBO Initiative: Accelerating Ibogaine Trials For Opioid Use Disorder

The Advanced Research Projects Agency for Health (ARPA‑H) has released Special Notice ARPA‑H‑SN‑26‑158 for ASCENT‑IBO: Accelerating Safe Clinical Evaluation of Novel Treatments – Ibogaine for Better Outcomes in OUD. This effort sits under the Proactive Health Office (PHO) Innovative Solutions Opening (ISO ARPA‑H‑SOL‑24‑106) and is directly tied to Executive Order 14401, which directs federal agencies

ARPA‑H’s ASCENT‑IBO Initiative: Accelerating Ibogaine Trials For Opioid Use Disorder Read More »

BARDA Signals Major NPIVS Contract For Pandemic Influenza Vaccines And Adjuvants

The Biomedical Advanced Research and Development Authority (BARDA) has quietly dropped a pre‑solicitation notice for a major, long‑term contract to sustain and expand the Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response Program, including the U.S. National Pre‑pandemic Influenza Vaccine Stockpile (NPIVS). The notice, posted July 30, 2026 under solicitation number 75A50126R00001, is

BARDA Signals Major NPIVS Contract For Pandemic Influenza Vaccines And Adjuvants Read More »

DOE Launches $81.9 Million Funding Opportunity to Advance Oil and Natural Gas Production and Delivery 

The U.S. Department of Energy (DOE), through its through its Division of Transport and Storage, has released a new Notice of Funding Opportunity titled “Advancing Oil and Natural Gas Production and Delivery” (DE-FOA-0003634). DOE plans to invest approximately $65.5 million in federal funding, paired with at least $16.4 million in required cost share, for a total of

DOE Launches $81.9 Million Funding Opportunity to Advance Oil and Natural Gas Production and Delivery  Read More »

DOE Signals $58 Million ASPECT Funding Opportunity for Emerging Chemical Technologies 

The U.S. Department of Energy (DOE), Office of Critical Minerals and Energy Innovation (CMEI), through the Alternative Fuels and Feedstocks Office (AFFO), has issued a Notice of Intent (NOI) for a forthcoming funding opportunity titled “Accelerating Scale-up and Pre-piloting of Emerging Chemical Technologies (ASPECT)” (DE-FOA-0003646). DOE anticipates releasing the full Notice of Funding Opportunity (NOFO) on

DOE Signals $58 Million ASPECT Funding Opportunity for Emerging Chemical Technologies  Read More »

Coming Soon From ARPA-H: FASTPASS For Rapid Screening of Medicines  

The Advanced Research Projects Agency for Health (ARPA‑H) is launching the Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program to tackle a critical, often invisible problem in the U.S. healthcare system: substandard and contaminated medicines slipping through the supply chain. Drug-related morbidity and mortality cost the system an estimated $528 billion per year and recalls affect the

Coming Soon From ARPA-H: FASTPASS For Rapid Screening of Medicines   Read More »

BARDA Seeks Advanced Dermal Regeneration Solutions for Severe Burns

The Biomedical Advanced Research and Development Authority (BARDA) has issued a Sources Sought Notice titled “Advanced Dermal Regeneration Substitutes for Treatment of Severe Burns and Complex Traumatic Injuries” (BARDA-CBRN-07282026) to identify commercially available or near commercial technologies that address large-area skin loss from burns and traumatic injuries in a mass casualty setting. This notice is for

BARDA Seeks Advanced Dermal Regeneration Solutions for Severe Burns Read More »

Scroll to Top